It is now possible to combine antigens with specific adjuvant systems to create more effective vaccines.
Nathalie Garçon, PhD
Advertisement
Nathalie Garçon, PhD, is the vice president and head of the Global Adjuvant Center for Vaccines at GlaxoSmithKline Biologicals, Wavre, Belgium, +32 (0)1 085 8856, nathalie.garcon@gskbio.com.
Articles by Nathalie Garçon, PhD
Advertisement
Latest Updated Articles
Addressing Unmet Medical Needs Through Tailored Vaccine Design: The Importance of Adjuvant SystemsPublished: October 1st 2009 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Regulatory Challenges for Global Manufacturing of Vaccines
2
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
3
AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D
4
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
5
